March 26 (Reuters) - New York is set to become the sixteenth U.S. state to legalize
recreational use of marijuana as a bill approved on Tuesday by the state's Senate and Assembly
heads to Governor Andrew Cuomo's desk for his signature.
Below are the eight publicly traded companies that currently hold medical marijuana licenses
in the state and are among those likely to benefit quickly from the legal changes to
recreational use.
Company RIC Market Value 2020 sales Footprint
Curaleaf Holdings Inc CURA.CD $10,079 $626.6 23 states
Green Thumb Industries Inc GTII.CD $7,005 $556.6 12 states
Cresco Labs CL.CD $6,006 $476.3 9 states
Columbia Care Inc CCHW.NLB $2,001 $197.9 15 states
Acreage Holdings Inc ACRGau.CD $350 $114.5 12 states
MedMen Enterprise Inc MMEN.CD $213 $157.1 6 states
Vireo Health International Inc VREO.CD $137 $49.2 8 states
iAnthus Capital Holdings Inc IAN.CD $55 $105.7* 11 states
Note: Market value, sales data in millions
* iAnthus 2020 sales are for the first 9 months
Source: New York State Department of Health; company records
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
BUZZ-Empire state of mind: New York lawmakers agree on weed legalization urn:newsml:reuters.com:*:nL4N2LN3K5
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Reporting by Shariq Khan in Bengaluru; Editing by Ramakrishnan M.)
((Shariq.Khan@thomsonreuters.com; Within U.S.+1 646 223 8780, outside U.S. +91 80 6182 2681;
Twitter: @shariqrtrs;))